Novel Point-of-care Tools for Early Infant Diagnosis of HIV. WHO. (2017)


The advent of point-of-care (POC) Early Infant Diagnosis (EID) technologies is a breakthrough that creates the opportunity to increase coverage of EID testing. It will allow same-day test results and enable the initiation of earlier treatment, as well as address some of the key limitations of conventional EID networks – in particular long turnaround times for tests and high rates of loss to follow up.

Keywords: HIV, infants, diagnosis, testing, treatment



Download Publication

Guidelines on the Public Health Response to Pretreatment HIV Drug Resistance. WHO. (2017)


This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) among people without prior antiretroviral (ARV) drug exposure or people with prior ARV exposure who are initiating or reinitiating first-line antiretroviral therapy (ART).

It also provides the consensus prevalence or threshold of pretreatment HIVDR to NNRTIs at which specific public health actions are triggered. This publication is a supplement to Chapter 4 of the 2016 WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2016 WHO consolidated ARV guidelines).


Keywords: HIVDR, ART, treatment, response, drug resistance


Download Publication

Guidelines for the Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy. WHO. (2017)


The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV. 


Keywords: HIV, ART, diagnosis, treatment, vaccination


Download Guidelines and Annexes

Global Action Plan on HIV Drug Resistance 2017–2021. WHO. (2017)


Preventing and managing the emergence of HIVDR is a key component of a comprehensive and effective HIV response, and should be integrated into broader efforts to ensure sustainability and greatest impact. It is essential that actions to monitor, prevent and respond to HIVDR are implemented at the clinical, programme and policy levels to address the many drivers of HIVDR.

The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant and breastfeeding women, children and adolescents. 


Keywords: HIV, prevention, response, monitoring, surveillance



Download Publication

HIV Drug Resistance Report 2017. WHO. (2017)


This second HIVDR report provides an update on recent population levels of HIVDR covering the period 2014–2016. The report includes data from 16 nationally representative surveys from 14 countries estimating resistance in: adults initiating ART (PDR), children younger than 18 months newly diagnosed with HIV, and adults on ART (acquired HIV drug resistance or ADR).

To contextualize results from representative HIVDR surveys, the report is supported by systematic reviews of the published literature on PDR in adults, children and adolescents, and ADR in paediatric and adult populations. 

Keywords: HIV, ART, drug resistance, treatment, prevalence



- HIV drug resistance report 2017


- Access policy brief: Tackling HIV drug resistance: trends, guidelines and global action

SDG Index and Dashboards Report 2017. Sachs J, Schmidt-Traub G, Kroll C, Durand-Delacre D and Teksoz K. (2017)


Agenda 2030 and the Sustainable Development Goals (SDGs), which were adopted by all member states of the United Nations in 2015, describe a universal agenda that applies to and must be implemented by all countries, both developed and developing. Sound metrics and data are critical for turning the SDGsinto practical tools for problem-solving by (i) mobilizing governments, academia, civil society, and business; (ii) providing a report card to track progress and ensure accountability; and (iii) serving as a management tool for the transformations needed to achieve the SDGsby 2030.

Keywords: SDG, HIV, Universal Health Coverage (UHC), development, data



Download Publication

HIV Prevention Research and Development Investments, 2000–2016: Investment Priorities to Fund Innovation in a Challenging Global Health Landscape. Resource Tracking for HIV Prevention Research and Development. (2017)


In its 13th annual report, the Resource Tracking for HIV Prevention Research & Development Working Group (“Working Group”) documents research and development spending for the calendar year 2016 and analyzes funding trends spanning 16 years.


Between 2000 and 2016, the Working Group has tracked over US$17 billion in investment towards biomedical HIV prevention research and development (R&D). The 2016 report analyzes over 600 donor-identified disbursements, as well as R&D spending trends for the following prevention options: AIDS vaccines, microbicides, pre-exposure prophylaxis (PrEP), treatment as prevention (TasP), medical male circumcision (VMMC), female condoms, prevention of vertical transmission (PMTCT) and HSV-2 vaccines. Cure research and therapeutic vaccine investments were also tracked as part of a comprehensive analysis of the HIV R&D landscape.

Keywords: AVAC, HIV, prevention, treatment, funding


Download Publication

UNAIDS Data 2017. UNAIDS. (2017)


UNAIDS has collected and published information on the state of the world’s HIV epidemic for the past 20 years. This information has shaped and guided the development of the response to HIV in regions, countries and cities worldwide. This edition of UNAIDS data contains the highlights of the very latest data on the world’s response to HIV, consolidating a small part of the huge volume of data collected, analysed and refined by UNAIDS over the years.


Keywords: HIV, AIDS, 90-90-90, deaths, new infections, prevalence, treatment, testing 



Download Publication

Ending AIDS: Progress towards the 90–90–90 Targets. UNAIDS. (2017)


Ending AIDS: progress towards the 90–90–90 targets, gives a detailed analysis of progress and challenges towards achieving the 90–90–90 targets. The report shows that for the first time the scales have tipped: more than half of all people living with HIV (53%) now have access to HIV treatment and AIDS-related deaths have almost halved since 2005. In 2016, 19.5 million of the 36.7 million people living with HIV had access to treatment, and AIDS-related deaths have fallen from 1.9 million in 2005 to 1 million in 2016. Provided that scale-up continues, this progress puts the world on track to reach the global target of 30 million people on treatment by 2020.


Keywords: HIV, AIDS, treatment, children, women and girls, young people, investment 


Download Documents


- Global AIDS Update 2017


- UNAIDS Data 2017 


- UNAIDS Fact Sheet


- Core Epidemiology Slides 2017


- Ending AIDS - Report Graphics Slides


WHO Technical Brief: Preventing HIV During Pregnancy and Breastfeeding in the Context of Pre-exposure Prophylaxis (PrEP). WHO. (2017)


PrEP could complement established HIV prevention strategies for pregnant and breastfeeding women as part of a comprehensive package to reduce HIV infections among women and transmission from mothers to infants in settings with high HIV incidence. 



Keywords: HIV, PMTCT, prevention, pregnant and breastfeeding women



Download Publication


Highlighted publications
Calendar of events
(28 Jul - 28 Jul)
(12 Aug - 12 Aug)